Related Experiment Video
Updated: Jan 9, 2026

04:04
Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
Published on: August 15, 2025
352
A Red Lobulated Facial Mass: A Clinicopathological Challenge
Shreya K Gowda1, Vanshika Arora1, Sudheer Arava2
1Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.
International Journal of Dermatology
|December 10, 2025
Summary
Rosai-Dorfman disease (RDD) is a rare histiocytosis. This case highlights successful treatment of facial RDD using systemic dapsone and surgical excision.
Area of Science:
- Dermatology
- Pathology
- Oncology
Background:
- Rosai-Dorfman disease (RDD) is a rare benign histiocytic proliferative disorder.
- Facial nodules are a common presentation, posing diagnostic and therapeutic challenges.
- Differential diagnoses include adult-onset xanthogranuloma, sarcoidosis, and anaplastic large cell lymphoma.
Purpose of the Study:
- To report a rare case of adult-onset RDD presenting as a progressive facial nodule.
- To emphasize the diagnostic utility of histopathology and immunohistochemistry in RDD.
- To highlight the efficacy of a combined therapeutic approach.
Main Methods:
- Histopathological examination with S100 staining and assessment for emperipolesis.
- Immunohistochemistry to differentiate from other histiocytic disorders.
- Treatment with systemic dapsone and serial surgical excisions.
Main Results:
- Histopathology confirmed RDD with S100-positive histiocytes exhibiting emperipolesis.
- The patient showed significant regression of the facial nodule with systemic dapsone (100 mg daily) over 1.5 years.
- Complete clearance was achieved after serial excision of the residual lesion.
Conclusions:
- RDD is characterized by S100+ histiocytes with emperipolesis.
- Systemic dapsone combined with serial surgical excisions can be an effective treatment for facial RDD.
- Early and accurate diagnosis is crucial for appropriate management of RDD.
Keywords:
Rosai–Dorfman diseaseXanthogranulomacutaneous RDDdermatofibrosarcoma protuberansfacial masssarcoidosis
